ISSN: 0301-472X

Journal Home

Journal Guideline

Experimental Hematology Q1 Unclaimed

Elsevier Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Experimental Hematology is a journal indexed in SJR in Cell Biology and Molecular Biology with an H index of 126. It has an SJR impact factor of 1,182 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,182.

Experimental Hematology focuses its scope in these topics and keywords: hematopoietic, marrow, bone, cell, stem, transcription, cells, control, factor, evolving, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Genetics (Q1) Hematology (Q1) Cancer Research (Q2) Cell Biology (Q2) Molecular Biology (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1,182

SJR Impact factor

126

H Index

78

Total Docs (Last Year)

260

Total Docs (3 years)

4141

Total Refs

685

Total Cites (3 years)

258

Citable Docs (3 years)

2.66

Cites/Doc (2 years)

53.09

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Nature Cell Biology Q1
Molecular Cell Q1
Genome Biology Q1
Nature Microbiology Q1
Cell Stem Cell Q1

Compare this journals

Aims and Scope

Best articles by citations

Effect of combined INTERLEUKIN-1-alpha (IL1-A), Cyclophosphamide (Ctx) Treatment on hematopoietic stem cell function and numbers

Gene transfer to ankyrin-deficient bone marrow corrects spherocytosis in vitro

The influence of different cryopreservation protocols on the recovery and engraftment potential of hematopoietic stem and progenitor cells.

Improved blood hematopoietic progenitor mobilization in myeloma patients following treatment with thalidomide

Cml patients with advanced phase disease retain clonogenic progenitor cells which are responsive to interferon alfa and STI571 in vitro

Immune responses of m-csf-r dna vaccine and its effects on hematopoiesis in mice

Ex vivo expansion of cord blood megakaryocytic cells

In vivo hematopoietic potential of human neuronal stem cells

Tristetraprolin is a regulator of granulocyte-macrophage colony-stimulating factor mRNA stability

All-trans-retinoic acid inhibits the erythroid differentiation program of human marrow CD34+ progenitors

PI3-Kinase may be involved in cml progenitor cell responses to interferon alfa and STI571

Residual erythroid progenitors present in w/w mice respond to erythropoietin in the absence of steel factor signals

SHOW MORE ARTICLES

Effects of anti-oxidants on normal and leukemic hematopoiesis

Genetic analysis of denritic cell and macrophage differentiation from myb-transformed myeloid cell lines

Feasibility and recent improvement of autologous stem cell transplantation for acute myelocytic leukemia in patients over 60 years of age

Identification of a 85.0/124.5 kd molecule with anti-homoaggregation activity on KG1a cell surface by a single chain antibody from a phage display library

GATA-1 Low mice respond more readily than their normal littermates to in vivo perturbations of erythropoiesis

Long-term, drug-dependent regulation of erythropoietin and hematocrit in mice following delivery of plasmids to skeletal muscle

Some evidences for an intracrine loop in the macrophage colony-stimulating factor (M-csf) System

Paroxysmal nocturnal hemoglobinuria Differential gene expression of EGR-1 and TAXREB107

SOCS3 Plays an important negative regulatory role in myeloid colony formation

Mechanism of benzene toxicity and leukemo-genicity

We Welcome a New Associate Editor

Cocultivation of umbilical cord blood cells with endothelial cells leads to extensive amplification of competent CD34+CD38- cells